Cardiopulmonary bypass (CPB) is used increasingly to correct cyanotic heart defects during early infancy, but myocardial dysfunction is often seen after surgical repair. This study evaluates whether starting CPB at a conventional, hyperoxic P02 causes an "unintentional" reoxygenation (ReO2) injury. We subjected Repair ofheart defects causing cyanosis is performed on cardiopulmonary bypass (CPB)I in early infancy with increasing frequency. Postoperative cardiac dysfunction is the major cause of morbidity and mortality despite successful surgical correction and is more common in infants than in adult cardiac patients (29). The conventional method ofstarting CPB in hypoxemic infants is to raise P02 to > 400 mmHg by mixing their blood with fluid in the extracorporeal circuit pre-circulated at hyperoxic levels. We have speculated that such abrupt reoxygenation causes an "unintended reoxygenation injury" (2) and adds to subsequent intraoperative oxidative stress due to surgical ischemia that provides a bloodless field, and limits the effectiveness of a cardioplegic strategy shown previously to reduce reperfusion damage (3, 4). Our hypothesis is based on experimental evidence that cyanosis reduces endogenous myocardial antioxidants and reoxygenation enhances free radical generation (5). In support of this hypothesis, clinical reports show myocardial lipid peroxidation in pre-ischemic biopsies from cyanotic children (6), cardioplegic protection is less adequate in cyanotic versus normoxic patients despite shorter ischemic intervals (7) and myocardial dysfunction in cyanotic infants placed on extracorporeal membrane oxygenation (ECMO) despite absence of surgical ischemia (8, 9) . Studies indicate reactive oxygen species mediate reperfusion/reoxygenation injury (10) via the classic Haber-Weiss (Fenton) pathway ( 1). An alternate mechanism of oxidant injury was proposed recently by Beckman et al.(4), whereby superoxide anion (O -) and nitric oxide (NO) interact to form cytotoxic 02 species ( 12). We showed recently cyanotic infantile hearts reoxygenated on CPB have a burst ofNO which was associated with oxidant damage and myocardial dysfunction which could be ameliorated by either adding a NO synthase (NOS) inhibitor or antioxidants to the priming solution ofthe CPB circuit (2). Unfortunately, NOS inhibition with a L-arginine analog produced severe systemic vasoconstriction and resulted in pancreatic damage despite its cardioprotective effect and the antioxidants added to the CPB prime are not available clinically.
Introduction
Cardiopulmonary bypass (CPB) is used increasingly to correct cyanotic heart defects during early infancy, but myocardial dysfunction is often seen after surgical repair. This study evaluates whether starting CPB at a conventional, hyperoxic P02 causes an "unintentional" reoxygenation (ReO2) injury. We subjected 2-wk-old piglets to ventilator hypoxemia (FIO2 -0.06, P02 25 mmHg) followed by 5 Repair ofheart defects causing cyanosis is performed on cardiopulmonary bypass (CPB)I in early infancy with increasing frequency. Postoperative cardiac dysfunction is the major cause of morbidity and mortality despite successful surgical correction and is more common in infants than in adult cardiac patients (29) . The conventional method ofstarting CPB in hypoxemic infants is to raise P02 to > 400 mmHg by mixing their blood with fluid in the extracorporeal circuit pre-circulated at hyperoxic levels. We have speculated that such abrupt reoxygenation causes an "unintended reoxygenation injury" (2) and adds to subsequent intraoperative oxidative stress due to surgical ischemia that provides a bloodless field, and limits the effectiveness of a cardioplegic strategy shown previously to reduce reperfusion damage (3, 4) . Our hypothesis is based on experimental evidence that cyanosis reduces endogenous myocardial antioxidants and reoxygenation enhances free radical generation (5) . In support of this hypothesis, clinical reports show myocardial lipid peroxidation in pre-ischemic biopsies from cyanotic children (6) , cardioplegic protection is less adequate in cyanotic versus normoxic patients despite shorter ischemic intervals (7) and myocardial dysfunction in cyanotic infants placed on extracorporeal membrane oxygenation (ECMO) despite absence of surgical ischemia (8, 9) . Studies indicate reactive oxygen species mediate reperfusion/reoxygenation injury (10) via the classic Haber-Weiss (Fenton) pathway ( 1) . An alternate mechanism of oxidant injury was proposed recently by Beckman et al.(4) , whereby superoxide anion (O -) and nitric oxide (NO) interact to form cytotoxic 02 species ( 12) . We showed recently cyanotic infantile hearts reoxygenated on CPB have a burst ofNO which was associated with oxidant damage and myocardial dysfunction which could be ameliorated by either adding a NO synthase (NOS) inhibitor or antioxidants to the priming solution ofthe CPB circuit (2) . Unfortunately, NOS inhibition with a L-arginine analog produced severe systemic vasoconstriction and resulted in pancreatic damage despite its cardioprotective effect and the antioxidants added to the CPB prime are not available clinically.
Alternative strategies do, however, exist during conventional cardiac operations that can reduce NO and 0-production. For example, generation of 0-and NO is P02 dependent (13, 14) , and controlling the rate of reintroduction of molecular oxygen when CPB is started and cardioplegic solution is administered may avoid the burst of NO and 0-that follows abrupt reoxygenation (2, 15 to provide control hemodynamic and biochemical data, since the hypoxia/reoxygenation studies (see below) had this duration.
Blood cardioplegia without hypoxemia. To test the safety of our blood cardioplegic protocol during surgical ischemia in immature hearts, six normoxic piglets (PO2 -100 mmHg) underwent 60 min of CPB at P02 400 mmHg without preceding hypoxemia. After 5 min of CPB, they underwent 30 min of aortic clamping with P02 400 mmHg blood cardioplegia. The cardioplegic formulation, as described in Table I, was developed experimentally (3), and is used clinically (23) . The blood cardioplegic protocol included warm cardioplegia (370C) for 3 min followed by cold cardioplegia for 2 min (40C), and a 3-min infusion of 370C blood cardioplegia just before aortic unclamping. Infusion rate was regulated by calibrated roller pump at 10 ml/kg/min initially to produce arrest and 5 ml/kg/min thereafter with aortic pressure averaging - Hypoxia/reoxygenation with surgical ischemia 19 hypoxic piglets were placed on CPB using either a hyperoxic (PO2 -400 mmHg), normoxic (PO2 -100 mmHg), or hypoxic (PO2 -25 mmHg) prime in the CPB circuit. After 5 min ofCPB, all piglets underwent 30 min of aortic clamping using the blood cardioplegia regimen described previously, followed by 25 min of reperfusion before discontinuing bypass. The CPB and blood cardioplegic P02 were adjusted as follows.
Initial hyperoxic CPB. Eight piglets underwent conventional reoxygenation on CPB at P02 -400 mmHg. After 5 min, the aorta was clamped and blood cardioplegia was delivered at pO2 400 mmHg. Initial normoxic CPB. In five piglets, CPB was started normoxically at P02 100 mmHg, and normoxic blood cardioplegia was delivered 5 min later. CPB P02 was raised to 400 mmHg after aortic unclamping. Initial hypoxic CPB. In six piglets, CPB was started at the ambient hypoxic P02 ('-25 mmHg during ventilator hypoxemia). Initial CPB flow was increased 50% during these 5 min (to 150 ml/kg) to augment tissue 02 delivery. Systemic and cardiac reoxygenation was delayed until blood cardioplegia was given; P02 was increased to 100 mmHg immediately after aortic clamping, and normoxic blood cardioplegia was given. P02 was raised to 400 mmHg after aortic unclamping.
Mean blood pressure was adjusted to 60-70 mmHg after cardiac contraction resumed. Piglets were observed for 30 min after CPB, while arterial blood gases and electrolytes were restored to normal levels. Final measurements ofbiochemical variables and contractile function were made 30 min after CPB. Hearts were then arrested with cold (40C) blood cardioplegia (KC1 30 mEq/l) to stop metabolism and a transmural left ventricular biopsy obtained ( -200 mg). The subendocardial portion was separated, frozen quickly in liquid nitrogen, and stored for biochemical analyses.
Physiologic and biochemical determinations
Hemodynamic measurements were made before starting hypoxia (control), every 15 min during hypoxia, and 15 and 30 min after discontinuing CPB. Cardiac output was determined by duplicate injections of I ml of 4VC cold saline into a central venous catheter. Cardiac index (CI), systemic vascular resistance index (SVRI), pulmonary vascular resistance index (PVRI), and left ventricular stroke work index (LV SWI) were calculated using the following equations: where MAP is mean aortic pressure, PAP is mean pulmonary artery pressure, LAP is mean left atrial pressure, CVP is central venous pressure, CO is cardiac output in ml/min, and HR is heart rate.
Myocardial performance
Left ventricular pressure and conductance catheter signals were amplified and digitalized to inscribe left ventricular pressure volume loops after correction for tissue conductance (24) . A series of pressure volume loops were generated under varying loading conditions by transient occlusion of the inferior vena cava during a 7-s period of apnea. Measurements were made before hypoxia (control) and 30 min after discontinuing CPB. The end-systolic pressure volume relationship (ESPVR) was analyzed using a computer graphics program ("Spectrum") on a 383/33 mHz IBM PC, and LV performance was determined from the descending slope using linear regression and designated end-systolic elastance (Ees) as described previously (25) . Post bypass LV contractility was expressed as percent recovery of prebypass control values (percent Ees). Pre-and post-CPB myocardial function was also evaluated using Starling curves by infusing CPB blood into the IVC at 5 ml/kg/min while recording CO, MAP, and LAP.
Myocardial nitric oxide production NO was determined in plasma by re-converting its oxidation end-products, nitrite (NO-) and nitrate (NO-), to NO and measuring chemiluminescence after NO reacts with ozone using a nitrogen oxides analyzer (DASIBI Environmental Corp., Model 2108, Glendale, CA) (26) . Blood samples were taken from coronary perfusate (blood cardioplegia) and coronary effluent (coronary sinus blood) to assess arterial-venous difference in NO during induction of blood cardioplegia. Production of NO was measured by the formula; NO production = CBF x V-A/ IOMg heart weight, where A and V are the respective concentrations ofNO measured in the aortic and coronary sinus blood during cardioplegic delivery when the cardioplegic solution was administered at a fixed coronary blood flow rate (CBF), by calibrated roller pump as described under control studies.
Myocardial oxidant injury
Myocardial conjugated diene production. Additional aliquots of coronary artery perfusate (blood cardioplegia) and coronary venous effluent were sampled to determine conjugated diene production. Samples were centrifuged immediately for 5 min at 1000 X g. Plasma was stored in liquid nitrogen for later measurements. Conjugated dienes were determined spectrophotometrically as described previously (2), and conjugated diene concentration expressed as absorbance (A) at a wavelength of233 nm. Conjugated diene production was calculated by the following formula; CBF (V -A)/ 100 g heart weight, where A and V are the concentration of conjugated dienes in the blood cardioplegic perfusate and coronary sinus effluent respectively, and CBF (coronary blood flow) is the blood cardioplegic flow rate in ml/min.
Antioxidant reserve capacity
The myocardial antioxidant state was assessed by determining in vitro lipid peroxidation in cardiac tissue that was homogenized and incubated with t-butyl hydroperoxide (t-BHP) at concentrations varying from 0 to 4 mM for 30 min at 37°C (27) . Lipid peroxidation was determined by measuring thiobarbituric acid (TBA) reactive substances spectrophotometrically at 532 nm. A standard curve is run simultaneously and expressed lipid peroxidation as nM malondealdehyde/gm protein. Protein was measured by the method ofLowry (28) .
Statistical analyses
Data were analyzed with Statview Version 2.0 (Abacus Concepts, Berkeley, CA). Analyses ofvariance (ANOVA) was used for comparison between groups. Differences were considered significant at P < 0.05. Group data are expressed as mean±SEM.
Results
Hemodynamics. The hemodynamic data in control studies and pre-and posthypoxic data in experimental studies are summarized in Table II. Hypoxemia caused tachycardia (heart rate increased from 170±10 to 206±15 beats/min), pulmonary vasoconstriction (PVRI increased 120±21%), peripheral vasodilation (SVRI decreased 34±12%) and an initial increase in cardiac output (28±8%). There was no statistically significant difference in bolus NaHCO3 injections (averaging 1-2/piglet) or duration of hypoxia among the groups (Table II) .
All piglets could support the circulation after CPB was discontinued, achieving normal to near normal cardiac output after volume infusion. A higher LAP was needed, however, to maintain the same LV stroke work index in piglets receiving uncontrol reoxygenation (Fig. 1 a) , and no further augmentation of stroke work index was achieved by volume infusion after LAP exceeded 8-10 mmHg.
LV contractility Reoxygenation on CPB without surgical ischemia. Reoxygenation with abrupt hyperoxic P02 (-400 mmHg) in the CPB circuit without superimposed ischemia (aortic crossclamp) was associated with only 25±5% recovery ofEes. Fig. 1 b shows the pressure volume relationships in a piglet undergoing abrupt reoxygenation on CPB, and Fig. 2 shows the percent recovery of Ef in all studies of reoxygenation without surgical ischemia.
Gradual reoxygenation performed by raising PO2 from 25 to 400 mmHg over 1 h reduced post-CPB myocardial dysfunction minimally, as Ees recovered to 34±4% of control.
Reoxygenation on CPB with surgical ischemia. In control studies, myocardial performance was unaffected by the surgical ship between pO2 during initiating ofCPB when initial P02 was hyperoxic (PO2 -400 mmHg, ), normoxic (PO2 -100 mmHg, i), or hypoxic (PO2 -25 mmHg, m). * P < 0.05 vs. control piglets undergoing CPB and BCP without preceding hypoxemia, t P < 0.05 vs. P02 400 mmHg, I P < 0.05 vs. P02 = 100 mmHg.
blood flow could not be measured without the aorta being clamped for cardioplegic delivery. Hyperoxic reoxygenation (PO2> 400 mmHg) on CPB was associated with an 1 -fold increase in NO production during cardioplegic induction compared to control piglets given the same hyperoxic blood cardioplegic solution. In contrast, this marked NO production was reduced by 70 and 94%, respectively, by controlling cardiac reoxygenation by (a) initiating CPB at normoxemic levels (PO2 -100 mmHg) or (b) starting CPB at ambient hypoxic PO2 -25 mmHg) and delaying reoxygenation until normoxemic blood cardioplegia was given (PO2 -100 mmHg) (Fig. 4) . Reoxygenation + BCP Figure 5 . Myocardial conjugated diene (CD) production (A233/min/ 100 g heart weight) during BCP induction in control piglets (no hypoxemia), and hypoxemic piglets reoxygenated on cardiopulmonary bypass with the circuit primed at hyperoxic; normoxic, and hypoxic P02 before undergoing surgical ischemia with BCP. Note negligible CD production in control piglets receiving BCP without preceding hypoxemia (), and direct relationship between P02 at start of CPB and CD production when initial P02 was hyperoxic normoxic or hypoxic. * P < 0.05 vs. control piglets undergoing CPB and BCP without preceding hypoxemia, P P < 0.05 vs. P02 400 mmHg, § P < 0.05 vs. P02 = 100 mmHg.
Myocardial conjugated diene production. The increase in conjugated diene production paralleled elevations in NO production (Figs. 4 and 5) . Negligible cardiac-conjugated diene production occurred in non-hypoxemic controlled piglets undergoing 30 min of surgical ischemia with blood cardioplegia, whereas hyperoxic reoxygenation on CPB caused a 10-fold increase in myocardial conjugated diene production during blood cardioplegic induction (Fig. 5) . Conversely, controlled cardiac reoxygenation limited conjugated diene production Reoxygenation + BCP Figure 4 . Myocardial nitric oxide production (M/min/ 100 g heart weight) during BCP induction in control piglets ( Antioxidant reserve capacity. Sudden and gradual reoxygenation to 400 mmHg on CPB without surgical ischemia caused a 68±5% and 44±8% reduction in antioxidant reserve capacity, respectively. A comparable 59±8% impairment occurred in piglets subjected to hyperoxic reoxygenation with subsequent surgical ischemia (Fig. 6) . In contrast, starting CPB at either normoxic or ambient hypoxic levels, followed by normoxemic blood cardioplegia in previously hypoxemic piglets limited the impairment in antioxidant reserve capacity (Fig. 6) .
Discussion
This in vivo study shows that abrupt reoxygenation ofcyanotic infantile piglets produces post-CPB myocardial mechanical dysfunction that is associated with augmented NO production provided that molecular 02 is reintroduced by the conventional clinical procedure of raising P02 to 400 mmHg in the extracorporeal circuit. Post-CPB cardiac dysfunction is associated with signs oflipid peroxidation and depletion ofmyocardial antioxidants. This reoxygenation damage (a) nullifies the cardioprotective effects of a blood cardioplegic solution, and (b) can be limited or prevented by controlled cardiac reoxygenation, whereby CPB is started using either a hypoxic or a normoxic priming fluid and delaying reoxygenation until the heart is given a normoxic cardioplegic solution developed originally for treating reperfusion injury ( 3,4) . The salutary effects ofinitiating hypoxic CPB seem related to offsetting reoxygenation injury by delaying reintroduction of molecular oxygen until blood cardioplegic induction, since gradual reoxygenation without blood cardioplegia produced only minimal benefits.
Role ofNO. Recent in vitro findings confirm that NO may reduce myocardial contractile dysfunction (29) , as originally reported in our in vivo reoxygenation study (2) . The present report quantifies a substantially greater production ofNO after reoxygenation than our previous report, since we determined actual production rates of nitrite and nitrate, rather than isolated, serum nitrite determinations alone. These data define a direct correlation between NO production during initial reoxygenation blood cardioplegic induction and the extent of oxidant injury based on conjugated diene production. Improved myocardial function and reduced lipid peroxidation was linked to a suppression of NO by controlling the process of cardiac reoxygenation. Potential sources of NO include the endothelium, myocytes, endocardium and mitochondria ( 18) , but this study does not distinguish their relative contribution to the observed damage. The relative roles of individual elements in the blood cardioplegic solution in suppressing NO production is also not examined.
Arginine is the biochemical precursor ofNO and is physiologically responsible for endothelial-derived relaxation. Nitric oxide inhibits vascular adherence of neutrophils, perhaps accounting for the salutary effects of L-arginine in the ischemic/ reperfusion model (30) , where blood flow is stagnant and neutrophils become adherent during ischemia and activated during reperfusion (31) . Conversely, L-arginine accelerates reoxygenation damage in the in vivo hypoxemic model where coronary blood flow is high, and neutrophil adherence is less likely. Clearly, a balance between the physiologic and pathologic effects of nitric oxide must be established. Furthermore, lactate accumulation may down regulate metabolism during ischemia and provide reducing equivalents during reperfusion (32) , whereas the high coronary flow during hypoxemia prevents lactate buildup.
NO production during cardioplegic induction in previously hypoxemic piglets paralleled the initial P02 level in the extracorporeal circuit. These in vivo findings documenting the relationship between NO and PO2 are consistent with recent in vitro studies showing the V. of constitutive NO synthase is related to 02 tension ( 13) . We likely underestimated the true burst of NO with reoxygenation, as coronary blood flow was measured only when blood cardioplegia was delivered 5 min after starting CPB. Despite delayed measurements, NO production increased 11-fold in previously hypoxemic hearts placed on CPB at P02 400 mmHg where a similar hyperoxic blood cardioplegic formulation did not cause NO production, conjugated diene generation or myocardial dysfunction under control conditions. We speculate that the excess NO reacts with°2-and generates the intermediate OONO-which decomposes to generate highly toxic 02 and N2 intermediates that produce lipid peroxidation. Encroachment on antioxidant reserve capacity occurred only in piglets subjected to uncontrolled reoxygenation and increased susceptibility to a subsequent ischemic insult, such as the interval of aortic clamping neo1ed to optimize operating conditions. The significant increase in nitric oxide content observed in coronary venous blood when the hypoxic heart-was abruptly reoxygenated may result in adverse biochemical reactions besides those related to peroxynitrite formation. NItric oxide mediates iron release from ferritin, the protein that stores excess intracellular iron (33) . Heme and non-heme-iron proteins may also be a source ofiron release by nitric-oxide (34) . Recent studies demonstrated an 8-9-fold rise in iron content of coronary blood when flow is re-established after myocardial ischemia (35) . Mobilized ferrous iron, released by nitric oxide, is thereby available to react with hydrogen peroxide which also increases with cardiac reoxygenation. Thus, nitric oxide may participate in the Haber-Weiss reaction, but by mechanisms that were not previously appreciated. Increased nitric oxide production and free iron release during reoxygenation is consistent with experimental7 and clinical"8 studies showing the importance of deferoxamine, an iron chelator, in preventing reperfusion-related myocardial damage after CPB.
The possibility exists that there is an NO paradox, just like an 02 (38) and calcium paradox (38) , whereby a substance responsible for modulating several physiologic functions (i.e., vascular tone, white blood cell and platelet adherence) may become deleterious when produced in high concentrations upon reoxygenation. The confusion over how the same substance can be both salutary and detrimental is resolved by recognizing that substances may have different actions during vs. after reoxygenation.
Role ofpO2. Clinically, cardiopulmonary bypass in hypoxemic infants is initiated at high P02 (-400 mmHg) without consideration of the possible cytotoxic effects of abrupt reoxygenation. The current study shows that a brief (i.e., 5 min) interval ofuncontrolled reoxygenation during initial hyperoxic CPB produced sufficient reoxygenation injury to nullify the benefits of blood cardioplegia.
Free radical generation and subsequent myocardial injury after reoxygenation are proportionate to oxygen tension ( 14, 38, 39) . Unfortunately, gradual reoxygenation alone reduced damage only marginally ifunaccompanied by blood cardioplegia. We suspect that delaying reoxygenation avoided the burst of NO and O-associated with abrupt reoxygenation, since initiating CPB at a hypoxic P02 (-25 mmHg) followed by reoxygenation with normoxic blood cardioplegia resulted in negligible NO production, avoided lipid peroxidation, and preserved antioxidant reserve capacity. The p02-dependent nature ofthis reoxygenation injury was evident from the findings where intermediate results followed initiation of normoxic CPB at P02
of approximately 100 mmHg (Figs. 3-5 ).
Controlled cardiac reoxygenation with blood cardioplegia.
Our findings documenting near complete functional recovery after controlled cardiac reoxygenation are consistent with previous observations where controlled reperfusion was used after regional and global ischemia (4, 40, 41) . In addition to the benefits of regulating pO2 when CPB was initiated, we speculate that several aspects of controlled cardiac reoxygenation with blood cardioplegia limited reoxygenation damage as enumerated previously (3, 4) and by some recently defined mechanisms described below.
Normothermic potassium arrest with hypocalcemic, alkalotic blood. The importance of initiating reoxygenation in the normothermically arrested state is underscored by the finding that reoxygenation hypercontraction and sarcolemmal disruption can be prevented by temporary contractile blockade (42) . This suggests that some of the limited energy produced during initial reoxygenation is used to normalize cytosolic Ca2 , presumably by improving Na'-Ca2' exchange (43) . Recent studies link reoxygenation to intracellular calcium loading and membrane damage (44) . Hypocalcemia may also limit activation of phospholipases which degrade membrane phospholipids, and lower release of reactive oxygen intermediates via the arachidonic acid and xanthine oxidase pathways (45) . It (46) , and is regulated by the cationic amino acid transport system that can be inhibited by L-glutamine and neutral amino acids ( 19 ) . Glutamine synthetase, present in cardiac muscle, converts glutamic acid to L-glutamine (20) , and L-glutamine is synthesized also from aspartate via aspartate aminotransferase (21) . In addition to their effect on cardiac energy metabolism, these observations imply that glutamate and aspartate via their conversion to Lglutamine may inhibit L-arginine transport and subsequent NO production.
Reduced reperfusion pressure. Reducing coronary artery pressure during reperfusion improves endothelial-dependent function (47) . This was ascribed initially to a reduction in mechanical damage to vulnerable endothelial cells, but endothelium-derived NO is linked closely to sheer stress (22) , so that decreasing sheer stress by gentle reperfusion may limit the NO that is generated.
PO2 in blood cardioplegia. Although lowering P02 in the CPB circuit had negligible effect on reducing reoxygenation injury without blood cardioplegia, PO2 in the blood cardioplegic solution may influence the effectiveness ofdifferent factors in the blood cardioplegic strategy, since°2 and NO production are P02 dependent ( 13, 14) . Hyperoxic blood cardioplegia is probably never needed, since normoxia (PO2 -100 mmHg)
provides nearly complete 02 saturation and 02 demands are negligible in the arrested decompressed heart (48) . Clinical implications. Our data suggest that an "unintentional" cardiac reoxygenation injury can be produced by the conventional procedure of instituting hyperoxic CPB. This inference is weakened, somewhat, because of the uncertain relevance ofthe acutely hypoxic model to the patient with chronic cyanosis who develops myocardial metabolic adaptations to hypoxemia (49) . The incidence ofpre-bypass dysfunction was, however, common to all groups and recovery occurred only in piglets undergoing controlled cardiac reoxygenation.
Our findings are consistent also with observations of patients with chronic cyanosis due to Tetralogy of Fallot who exhibit reduced endogenous antioxidant levels (i.e., glutathione peroxidase, SOD) (50), enhanced vulnerability to oxidant damage (51) , and increased conjugated diene production in pre-ischemic myocardial biopsies after conventional CBP is started (6) . This myocardial reoxygenation changes may increase vulnerability to subsequent ischemic/reperfusion injury in the surgical setting and contribute to post-bypass cardiac dysfunction, where standard methods of blood cardioplegic protection are less cardioprotective compared with acyanotic adult patients undergoing coronary revascularization despite shorter ischemic intervals (7) .
The functional depression quantified by the sensitive indices (Ees) and inscription of ventricular function curves may seem incompatible with the "uneventful" postoperative course after straightforward repair of cyanotic children with pulmonary stenosis or Tetralogy ofFallot. All piglets could be weaned from cardiopulmonary bypass and depressed function was defined by reduced Ees and normal cardiac output at increased filling pressures. This impairment offunction may not be appreciatedfrom the bedside wherefunctional reserve is not tested.
Our findings may explain why inotropic support is often needed postoperatively in cyanotic children. The occurrence of reoxygenation injury is evident also in cyanotic infants who undergo extracorporeal membrane oxygenation (ECMO) for respiratory failure, as reduced systolic function which progresses to "cardiac stun" occurs despite no surgical ischemia (8, 9).
We interpret our data to suggest that altering routine techniques ofconventional cardiopulmonary bypass may limit cardiac reoxygenation damage, and that the observed injury may be related to augmented NO production when CPB is started.
Initiation of CPB at hypoxic P02 reduces NO production and would likely be safe since the flow in the extracorporeal circuit could be augmented to ensure tissue 02 delivery when bypass is started. Furthermore, normoxic initiation on CPB at P02 -100 mmHg ensures 99% oxygen saturation without ad-justment ofthe CPB flow, and it is unlikely that hyperoxic CPB is ever needed in clinical practice, since P02 > 100-150 mmHg confers only negligible increase in oxygen content. The avoidance of hyperoxia during reoxygenation in cyanotic hearts to reduce reoxygenation injury may, in a sense, be comparable to restricting inspired F102 in newborn infants to avoid retrolental fibroplasia (52) . The techniques of controlled cardiac reoxygenation used in this study are available in routine practice, and can hopefully be used to limit cardiac reoxygenation injury during repair of congenital defects causing cyanosis.
